retatrutide glp 1 10mg & 20mg Research Peptide Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
Similar content being viewed by others Introduction Weight regain (WR) and insufficient weight loss (IWL) are significant challenges faced by 2025% of patients following bariatric surgery, often stemming from a combination of anatomical variations, genetic predispositions, hormonal imbalances, dietary noncompliance, and inadequate physical activity [1,2,3]
News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Jensen et al., JAMA Netw Open (2024)
Outside of the GI system, GLP-1 agonist medication actions lower blood pressure and improve lipid profiles, though the mechanisms of these actions are not fully understood
